Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Pediatr Neurol. 2013 Sep;49(3):156–162.e1. doi: 10.1016/j.pediatrneurol.2013.06.006

Table 2.

Comparison of variation for leukodystrophy patients across PHIS children’s hospitals, for years 2004–2010. All numbers refer to leukodystrophy patients. Results are total for the 7-year period. Mortality rate is calculated as a percent of the total leukodystrophy patient cohort at each hospital. The cost/patient is the total cost of in-patient health care costs for each leukodystrophsy patient.

Measure Total Average/Hospital Range
Number of patients 3,143 81 14–172
Number of admissions (n) 13,554 348 81–705
Admissions/patient --- 4.3 3.0–7.3
Mortalities (n) 268 6.9 1–17
Mortality % --- 8.8 2.4–18.1
Hospital costs ($thousands) 411,374 10,548 1,835–27,602
Cost/patient ($) --- 131,380 60,013–239,872
Total hospital days 136,776 3,507 826–7,307
Average length of stay/patient (days) --- 10.1 6.7–14.1
MRIs (n) 4,755 122 15–292
MRI/patient --- 1.5 0.7–2.5